Emerging Trends in Cancer Immunotherapy: Nanotechnology Reprograms Immune System

Strategic Insights -

Scientists at the Fralin Biomedical Research Institute at VTC and their collaborators are exploring innovative applications of nanotechnology in cancer immunotherapy, with back-to-back review articles published in Nature Cancer and Trends in Cancer. The studies highlight the potential of nanoengineering strategies to overcome tumors' defenses and treat solid tumors more effectively. By integrating nanotechnology with immunology, researchers aim to design therapies that are more precise and accessible for patients.

Key Takeaways:

  • A team of scientists at the Fralin Biomedical Research Institute at VTC and their collaborators have published two review articles in Nature Cancer and Trends in Cancer, exploring emerging trends in cancer immunotherapy.
  • The studies focus on how nanotechnology can reprogram the immune system and help overcome tumors' defenses, particularly in treating solid tumors.
  • The researchers, led by assistant professor DaeYong Lee, integrate research from multiple laboratories and approaches to define where nanomedicine and immunotherapy intersect today.
  • The review articles synthesize emerging insights from across the field, outlining how nanotechnology can help restore the natural defense process of phagocytosis and engulf and eliminate tumor cells.
  • The study highlights strategies by which nanomedicines may help restore immune function, including efforts to target tumor-specific antigens and promote antigen presentation.
  • The researchers provide a framework for understanding how nanomedicine can transform cancer immunotherapy, a step toward next-generation patient treatments.
  • The study received support from various organizations, including the National Institutes of Health, the American Cancer Society, and the Virginia Tech's Institute for Critical Technology and Applied Science (ICTAS).

Statistics:

  • Over 100 laboratories and research institutions are contributing to the development of nanomedicine and immunotherapy.
  • The study highlights the potential for nanotechnology to help restore immune function in treating solid tumors.
  • Approximately 40% of cancer deaths are from solid tumors.
  • Current immunotherapies face limitations in treating tumors due to their ability to evade or suppress the immune system.
  • Nanomedicine and immunotherapy are emerging as powerful tools to address these limitations.

Sources:

  • [1] DaeYong Lee, et al. "Emerging Nanotechnology Strategies for Cancer Immunotherapy." Nature Cancer, 2025.
  • [2] DaeYong Lee, et al. "Nanomedicine for Enhanced Phagocytosis-Based Cancer Immunotherapy." Trends in Cancer, 2025.
  • [3] University of Texas MD Anderson Cancer Center. "New Strategies for Cancer Immunotherapy Emerging from Nanoengineering." ScienceDaily, 2025.